Tartary buckwheat shown to improve lipid profile, reduce insulin resistance


Tartary buckwheat (Fagopyrum tataricum) can improve insulin resistance and lipid profile in people with Type 2 diabetes, according to a study published in Nutrition Research. The multi-university research investigated the effects of substituting certain foods with tartary buckwheat.

  • Tartary buckwheat is nutrient-dense; it contains protein, dietary fiber, and flavonoids.
  • Tartary buckwheat is also reported to improve Type 2 diabetes symptoms, based on in vivo tests; however, available research on whether it can be used as a whole food for Type 2 diabetics is limited.
  • The researchers enrolled 165 patients with Type 2 diabetes in a parallel, randomized, open-label, controlled trial. The participants were assigned to either a control diet group, which received systematic diet plans and intensive nutritional education, or an intervention group, which had a portion of their staple food replaced with tartary buckwheat.
  • Researchers also collected blood samples and diet information at baseline and after four weeks of intervention.
  • Participants in the intervention group reported a decrease in their fasting insulin (2.46-2.39 Ln mU/L), total cholesterol (5.08-4.79 mmol/L), and low-density lipoprotein cholesterol (3.00-2.80 mmol/L) levels after four weeks. These results were better compared to those in the control diet group.
  • Between the intervention and control groups, no significant differences in blood glucose or glycated hemoglobin levels were reported.
  • Subgroup analysis also revealed that taking tartary buckwheat resulted in a dose-reduction of insulin, total cholesterol, and low-density lipoprotein cholesterol, but only in doses lower than 110 g/d.

In conclusion, taking tartary buckwheat can improve insulin resistance and lipid profile in patients with Type 2 diabetes.

Journal Reference:

Qiu J, Liu Y, Yue Y, Qin Y, Li Z. DIETARY TARTARY BUCKWHEAT INTAKE ATTENUATES INSULIN RESISTANCE AND IMPROVES LIPID PROFILES IN PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED CONTROLLED TRIAL. Nutrition Research. December 2016;36(12):1392–1401.  DOI: 10.1016/j.nutres.2016.11.007


Submit a correction >>

Get Our Free Email Newsletter
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.
Your privacy is protected. Subscription confirmation required.


Comments
comments powered by Disqus

Get Our Free Email Newsletter
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.
Your privacy is protected. Subscription confirmation required.

RECENT NEWS & ARTICLES

Get the world's best independent media newsletter delivered straight to your inbox.
x

By continuing to browse our site you agree to our use of cookies and our Privacy Policy.